BROOKLYN IMMUNOTHERAPEUTICS (BTX)
US1140821000 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -107.29M | -122.31M | -4.42M | -2.05M | -259.00K | |||
| Depreciation Amortization | 157.51K | 117.00K | 1.74M | 2.88M | 2.76M | |||
| Change In Working Capital | -919.73K | -2.35M | -1.08M | -374.00K | -2.70M | |||
| Interest Paid | 239.00K | 225.00K | 96.00K | 246.00K | 336.00K | |||
| Taxes Paid | N/A | 1.00K | 26.00K | 26.00K | 17.00K | |||
| Other non cash items | 85.38M | 101.05M | -134.00K | 2.29M | 1.56M | |||
| OPERATING CASH FLOW | -22.68M | -23.49M | -3.89M | 2.74M | 1.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -387.00K | -154.00K | -266.00K | -1.09M | -1.61M | |||
| Other Investing Activity | -22.75M | -22.59M | 1.23M | 29.00K | 33.00K | |||
| INVESTING CASH FLOW | -23.14M | -22.74M | 960.00K | -1.06M | -1.58M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -410.01K | -942.00K | 356.00K | -1.04M | -1.62M | |||
| Stock Issued/Repurchased | 15.49M | 62.53M | N/A | 0.00 | 1.38M | |||
| Dividend Paid | N/A | -8.00K | -16.00K | -16.00K | -16.00K | |||
| Other Financing Activity | N/A | N/A | -49.00K | -37.00K | -40.00K | |||
| FINANCING CASH FLOW | 15.06M | 61.59M | 291.00K | -1.10M | -303.00K | |||
| Exchange Rate Effect | N/A | N/A | 11.00K | 42.00K | -75.00K | |||
| CHANGE IN CASH | -30.76M | 15.35M | -2.63M | 623.00K | -592.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.68M | -23.49M | -3.89M | 2.74M | 1.36M | |||
| Capital Expenditure | -387.00K | -154.00K | -266.00K | -1.09M | -1.61M | |||
| FREE CASH FLOW | -23.07M | -23.64M | -4.16M | 1.65M | -247.00K | |||
All data in USD